Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study
- PMID: 10372242
- DOI: 10.2337/diacare.22.6.920
Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study
Abstract
Objective: To determine whether the new category of impaired fasting glucose (IFG) recently proposed by the Expert Committee of the American Diabetes Association is a risk factor for cardiovascular disease.
Research design and methods: Death certificates and residence transfer documents from the cohort population consisting of participants of the diabetes prevalence study in Funagata, Yamagata prefecture, Japan, 1990-1992, were analyzed up through the end of 1996. First, the cohort population was classified into three groups: normal glucose tolerance (NGT) (n = 2,016), impaired glucose tolerance (IGT) (n = 382), and diabetic (n = 253). Then the same population was reclassified into normal fasting glucose (NFG), IFG, and diabetic. The cumulative survival rates among the groups were compared using the classical life-table method, and age-adjusted analyses, the person-year method, and Cox's proportional hazard model were adopted.
Results: At the end of seven observed years, the cumulative survival rates from cardiovascular disease of IGT and diabetes were 0.962 and 0.954, respectively, both significantly lower than that of NGT (0.988). The Cox's proportional hazard model analysis showed that the hazard ratio of IGT to NGT on death from cardiovascular disease was 2.219 (95% CI 1.076-4.577). However, the cumulative survival rate of IFG from cardiovascular disease was 0.977, not significantly lower than that of NFG (0.985). The Cox's hazard ratio of IFG to NFG on death from cardiovascular disease was 1.136 (0.345-3.734), which was not significant either.
Conclusions: IGT was a risk factor for cardiovascular disease, but IFG was not.
Comment in
-
Impaired glucose tolerance. Why is it not a disease?Diabetes Care. 1999 Jun;22(6):883-5. doi: 10.2337/diacare.22.6.883. Diabetes Care. 1999. PMID: 10372235 Review. No abstract available.
-
Impaired fasting glucose and cardiovascular disease.Diabetes Care. 1999 Nov;22(11):1919-20. doi: 10.2337/diacare.22.11.1919a. Diabetes Care. 1999. PMID: 10546043 Clinical Trial. No abstract available.
-
Impaired fasting glucose is not a risk factor for cardiovascular mortality.Diabetes Care. 1999 Dec;22(12):2104. doi: 10.2337/diacare.22.12.2104b. Diabetes Care. 1999. PMID: 10587865 No abstract available.
Similar articles
-
Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.Cardiovasc Diabetol. 2020 Mar 30;19(1):41. doi: 10.1186/s12933-020-01017-4. Cardiovasc Diabetol. 2020. PMID: 32228577 Free PMC article.
-
Comparison of glucose tolerance categories in the Korean population according to World Health Organization and American Diabetes Association diagnostic criteria.Korean J Intern Med. 2000 Jan;15(1):37-41. doi: 10.3904/kjim.2000.15.1.37. Korean J Intern Med. 2000. PMID: 10714090 Free PMC article.
-
Impaired glucose tolerance is a risk factor for stroke in a Japanese sample--the Funagata study.Metabolism. 2008 Mar;57(3):333-8. doi: 10.1016/j.metabol.2007.10.007. Metabolism. 2008. PMID: 18249204
-
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.Diabet Med. 2002 Sep;19(9):708-23. doi: 10.1046/j.1464-5491.2002.00835.x. Diabet Med. 2002. PMID: 12207806 Review.
-
[The Funagata study--impaired glucose tolerance is a risk factor for stroke in a Japanese sample].Nihon Rinsho. 2010 May;68(5):843-6. Nihon Rinsho. 2010. PMID: 20446580 Review. Japanese.
Cited by
-
Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases.Diabetes Care. 2013 Jul;36(7):1988-93. doi: 10.2337/dc12-1577. Epub 2013 Feb 12. Diabetes Care. 2013. PMID: 23404299 Free PMC article.
-
GDF15 Is a Novel Biomarker for Impaired Fasting Glucose.Diabetes Metab J. 2014 Dec;38(6):472-9. doi: 10.4093/dmj.2014.38.6.472. Epub 2014 Dec 15. Diabetes Metab J. 2014. PMID: 25541611 Free PMC article.
-
Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin.Diabetologia. 2004 Mar;47(3):385-394. doi: 10.1007/s00125-004-1334-6. Epub 2004 Feb 18. Diabetologia. 2004. PMID: 14985967
-
Role of melatonin in metabolic regulation.Rev Endocr Metab Disord. 2009 Dec;10(4):261-70. doi: 10.1007/s11154-009-9117-5. Rev Endocr Metab Disord. 2009. PMID: 19911281 Review.
-
Thyroid Function and the Risk of Prediabetes and Type 2 Diabetes.J Clin Endocrinol Metab. 2022 May 17;107(6):1789-1798. doi: 10.1210/clinem/dgac006. J Clin Endocrinol Metab. 2022. PMID: 35137143 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical